Table S2 from Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects

crossref(2024)

引用 0|浏览1
暂无评分
摘要

Table S2 is the list of primary antibodies used for immunoblotting assays in the study.

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要